Taken together, these findings reveal that ectopic expression of Neurod1 is sufficient to improve functional outcomes following stroke as early as 3 weeks post-transduction and maintain recovery to at least 8 weeks post-intervention. This evidence concerns the gene NEUROD1 and stroke disorder.